David W. Uster

A Model Averaging/Selection Approach Improves the Predictive Performance of Model‐Informed Precision Dosing: Vancomycin as a Case Study

David W. Uster, Sophie L. Stocker, Jane E. Carland et al. · Clinical Pharmacology & Therapeutics · 2020 · 73 citations

A Machine Learning Approach to Predict Interdose Vancomycin Exposure

Mehdi Bououda, David W. Uster, Egor Sidorov et al. · Pharmaceutical Research · 2022 · 44 citations · Full text

Antimicrobial Susceptibility, Predictive Toxicology, Antibiotics +6

Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients

C. Cunio, David W. Uster, Jane E. Carland et al. · Clinical Microbiology and Infection · 2020 · 40 citations

Therapeutic Drug Monitoring, Towards Precision Dosing, Antibiotics +10

Model-informed precision dosing of vancomycin via continuous infusion: a clinical fit-for-purpose evaluation of published PK models

Astrid Heus, David W. Uster, Veerle Grootaert et al. · International Journal of Antimicrobial Agents · 2022 · 23 citations

Precision Dosing, Model-informed Precision Dosing, Preclinical Drug Evaluation +9

Optimized sampling to estimate vancomycin drug exposure: Comparison of pharmacometric and equation‐based approaches in a simulation‐estimation study

David W. Uster, Sebastian G. Wicha · CPT Pharmacometrics & Systems Pharmacology · 2022 · 14 citations · Full text